Craig Gilliam will review the use of combination categories of precautions to meet symptom based systems
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, is hosting a complimentary webinar with Craig Gilliam, BSMT, CIC in "Controversies in Pediatric Isolation Precautions."
Isolation precautions are a recognized tool to prevent transmission of communicable diseases (original intent) and drug resistant isolates (more recent intent). Pediatric isolation precautions presents challenges for the healthcare worker as well adult caregiver.
Gilliam will review the use of combination categories of precautions to meet symptom based systems, which can be successful in situations where limited laboratory support for diagnostic testing is an issue.
Controversies in Pediatric Isolation Precautions
Date: Wednesday, August 20, 2014
Time: 1:00 PM - 2:00 PM ET
About the Presenter
Craig H Gilliam, BSMT, (ASCP) CIC received his Bachelor of Science in Medical Technology from the University of Arkansas for Medical Sciences. He is Director of Infection Prevention at Arkansas Children's Hospital since 1991. His chief area of interest is reduction of central line associated bloodstream infection in the Pediatric and Neonatal Intensive Care Units. Over the last three years, he has worked on reducing healthcare associated infections with improvement science techniques.
In 2007, he co-authored an article in the British Medical Journal on reduction of catheter bloodstream infections in the PICU. Also he was named one of Heroes of Infection Prevention by the Association for Professionals in Infection Control and Epidemiology, Inc. In 2008, he was appointed to Arkansas Department of Health HAI Advisory Committee on public reporting on health care associated infections. In 2009, he was co-leader of ACH Task Force for control of H1N1 Influenza. In 2013 he was President of Certification Board of Infection Control and Epidemiology, Inc.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language ®, Lexicomp ®, Lippincott Williams & Wilkins, Medicom®, Medi-Span ®, Medknow, Ovid ®, Pharmacy OneSource®, ProVation ® Medical and UpToDate ®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Follow our official Twitter handle: @WKHealth.